These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 32619652)

  • 21. Revisiting a receptor-based pharmacophore hypothesis for human A(2A) adenosine receptor antagonists.
    Bacilieri M; Ciancetta A; Paoletta S; Federico S; Cosconati S; Cacciari B; Taliani S; Da Settimo F; Novellino E; Klotz KN; Spalluto G; Moro S
    J Chem Inf Model; 2013 Jul; 53(7):1620-37. PubMed ID: 23705857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 3D-QSAR and docking studies on adenosine A2A receptor antagonists by the CoMFA method.
    Pourbasheer E; Shokouhi Tabar S; Masand VH; Aalizadeh R; Ganjali MR
    SAR QSAR Environ Res; 2015 Jun; 26(6):461-77. PubMed ID: 26055215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of anti-Parkinson's Disease Lead Compounds from Aspergillus ochraceus Targeting Adenosin Receptors A
    Hu L; Tian S; Wu R; Tong Z; Jiang W; Hu P; Xiao X; Zhang X; Zhou H; Tong Q; Lu Y; Huang Z; Chen Y; Zhang Y
    ChemistryOpen; 2021 Jun; 10(6):630-638. PubMed ID: 34102706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 8-(Furan-2-yl)-3-phenethylthiazolo[5,4-e][1,2,4]triazolo[1,5-c]pyrimidine-2(3H)-thione as novel, selective and potent adenosine A(2A) receptor antagonist.
    Kumari N; Mishra CB; Prakash A; Kumar N; Mongre R; Luthra PM
    Neurosci Lett; 2014 Jan; 558():203-7. PubMed ID: 24161891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of the selective adenosine A2A receptor antagonist, SCH 412348, on the parkinsonian phenotype of MitoPark mice.
    Smith KM; Browne SE; Jayaraman S; Bleickardt CJ; Hodge LM; Lis E; Yao L; Rittle SL; Innocent N; Mullins DE; Boykow G; Reynolds IJ; Hill D; Parker EM; Hodgson RA
    Eur J Pharmacol; 2014 Apr; 728():31-8. PubMed ID: 24486705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progress in pursuit of therapeutic A2A antagonists: the adenosine A2A receptor selective antagonist KW6002: research and development toward a novel nondopaminergic therapy for Parkinson's disease.
    Kase H; Aoyama S; Ichimura M; Ikeda K; Ishii A; Kanda T; Koga K; Koike N; Kurokawa M; Kuwana Y; Mori A; Nakamura J; Nonaka H; Ochi M; Saki M; Shimada J; Shindou T; Shiozaki S; Suzuki F; Takeda M; Yanagawa K; Richardson PJ; Jenner P; Bedard P; Borrelli E; Hauser RA; Chase TN;
    Neurology; 2003 Dec; 61(11 Suppl 6):S97-100. PubMed ID: 14663020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An overview of adenosine A2A receptor antagonists in Parkinson's disease.
    Jenner P
    Int Rev Neurobiol; 2014; 119():71-86. PubMed ID: 25175961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Istradefylline, a novel adenosine A2A receptor antagonist, for the treatment of Parkinson's disease.
    Jenner P
    Expert Opin Investig Drugs; 2005 Jun; 14(6):729-38. PubMed ID: 16004599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Istradefylline: adenosine A2A receptor antagonist to reduce "OFF" time in Parkinson's disease.
    Paton DM
    Drugs Today (Barc); 2020 Feb; 56(2):125-134. PubMed ID: 32163528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A2A Adenosine Receptor Antagonists as Therapeutic Candidates: Are They Still an Interesting Challenge?
    Cacciari B; Spalluto G; Federico S
    Mini Rev Med Chem; 2018; 18(14):1168-1174. PubMed ID: 29692248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allosteric interactions between agonists and antagonists within the adenosine A2A receptor-dopamine D2 receptor heterotetramer.
    Bonaventura J; Navarro G; Casadó-Anguera V; Azdad K; Rea W; Moreno E; Brugarolas M; Mallol J; Canela EI; Lluís C; Cortés A; Volkow ND; Schiffmann SN; Ferré S; Casadó V
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):E3609-18. PubMed ID: 26100888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potent and selective adenosine A(2A) receptor antagonists: [1,2,4]-triazolo[4,3-c]pyrimidin-3-ones.
    Harris JM; Neustadt BR; Zhang H; Lachowicz J; Cohen-Williams M; Varty G; Hao J; Stamford AW
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2497-501. PubMed ID: 21398125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological interactions between adenosine A
    Pinna A; Serra M; Marongiu J; Morelli M
    Parkinsonism Relat Disord; 2020 Nov; 80 Suppl 1():S37-S44. PubMed ID: 33349579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Homology modeling of adenosine A2A receptor and molecular docking for exploration of appropriate potent antagonists for treatment of Parkinson's disease.
    Singh V; Somvanshi P
    Curr Aging Sci; 2009 Jul; 2(2):127-34. PubMed ID: 20021407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of Novel and Selective Adenosine A
    Tian S; Wang X; Li L; Zhang X; Li Y; Zhu F; Hou T; Zhen X
    J Chem Inf Model; 2017 Jun; 57(6):1474-1487. PubMed ID: 28463561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of aminoquinazoline derivatives as human A(2A) adenosine receptor antagonists.
    Zhou G; Aslanian R; Gallo G; Khan T; Kuang R; Purakkattle B; De Ruiz M; Stamford A; Ting P; Wu H; Wang H; Xiao D; Yu T; Zhang Y; Mullins D; Hodgson R
    Bioorg Med Chem Lett; 2016 Feb; 26(4):1348-54. PubMed ID: 26781932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Adenosine A2A Receptor Antagonists as a Treatment Option for Parkinson's Disease?].
    Jost WH; Tönges L
    Fortschr Neurol Psychiatr; 2022 Dec; 90(12):565-570. PubMed ID: 35226930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis and biological evaluation of Tozadenant analogues as adenosine A
    Renk DR; Skraban M; Bier D; Schulze A; Wabbals E; Wedekind F; Neumaier F; Neumaier B; Holschbach M
    Eur J Med Chem; 2021 Mar; 214():113214. PubMed ID: 33548636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A covalent antagonist for the human adenosine A
    Yang X; Dong G; Michiels TJM; Lenselink EB; Heitman L; Louvel J; IJzerman AP
    Purinergic Signal; 2017 Jun; 13(2):191-201. PubMed ID: 27915383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of novel adenosine A(2A) receptor antagonists by virtual screening.
    Langmead CJ; Andrews SP; Congreve M; Errey JC; Hurrell E; Marshall FH; Mason JS; Richardson CM; Robertson N; Zhukov A; Weir M
    J Med Chem; 2012 Mar; 55(5):1904-9. PubMed ID: 22250781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.